Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease With Motor Fluctuations
NCT07432958Phase 2Recruiting
- Start
- Feb 2026
- Primary completion
- Sep 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AP-472 in Parkinson's disease (PD). Started Feb 2026; status: recruiting.
02
Drugs
AP-472
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT07432958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07432958.